Larissa Helena Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Larissa Helena Torres has a total of 222 co-authors. Here are the top co-authors by number of shared publications:
- Tania Marcourakis
Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
13 shared publications - Carla Speroni Ceron
Department of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro Preto, Ouro Preto, Brazil
9 shared publications - Tiago Marques dos Reis
Universidade Federal de Alfenas
9 shared publications Raphael Caio Tamborelli Garcia
Department of Pharmaceutical Sciences, Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, SP, Brazil
8 shared publications- Raphael Caio Tamborelli Garcia
Department of Pharmaceutical Sciences, Institute of Environmental, Chemical and Pharmaceutical Sciences, Universidade Federal de São Paulo, Diadema, Brazil
7 shared publications - Márcia Helena Miranda Cardoso Podestá
Universidade Federal de Alfenas
6 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Fundacao Educacional de Formiga - FUOM in Conexão Ciência (Online)
- Vol. 21 (3) , 151-193
Eficácia e segurança dos tratamentos farmacológicos e cirúrgicos para tremor distônico: uma revisão sistemática
Introdução: O Tremor Distônico é um tipo de tremor de ação que surge no segmento afetado pela distonia. Seu tratamento inclui estratégias farmacológicas e invasivas, porém não há evidências suficientes para a tomada de decisão clínica. Objetivo: Revisar as evidências publicadas atualmente sobre eficácia e segurança do tratamento farmacológico e/ou cirúrgico para tratar tremor distônico em qualquer grau de gravidade. Metodologia: Foi uma revisão sistemática conduzida nas bases de dados eletrônicas Medline (via PubMed), Embase, Cochrane Library, Web of Science e Scopus (desde o início até 30 de janeiro de 2024). Dois revisores independentes realizaram a seleção, a extração de dados e a avaliação do risco de viés. A avaliação do risco de viés foi realizada utilizando as ferramentas “Risk-of-bias tool for randomized trials”, “Risk Of Bias In Non-randomized Studies-of Interventions” e a Escala de Newcastle Ottawa Modificada para estudos observacionais. Além disso, a qualidade da certeza de evidências foi avaliada por meio da “Grading os Recommendations Assessment, Development and Evaluation”. Resultados: Foram incluídos 36 estudos, sendo 11 relatos de caso e estudos de coorte cada, nove séries de casos e cinco ensaios clínicos, totalizando 512 participantes. Entre as intervenções descritas estavam tratamentos farmacológicos, estimulação transcraniana e procedimentos invasivos. Conclusão: Entre as intervenções identificadas, observou-se que 63,8% apresentaram relato de Estimulação Cerebral Profunda no qual foi observado provável benefício terapêutico na redução da gravidade do tremor. Os principais efeitos adversos com a realização da Estimulação Cerebral Profunda são disartria, instabilidade da marcha ou ataxia e parestesia.
- 8 October 2026
- Published by Fundacao Educacional de Formiga - FUOM in Conexão Ciência (Online)
- Vol. 21 (3) , 151-193
Open AccessEficácia e segurança dos tratamentos farmacológicos e cirúrgicos para tremor distônico: uma revisão sistemática
Introdução: O Tremor Distônico é um tipo de tremor de ação que surge no segmento afetado pela distonia. Seu tratamento inclui estratégias farmacológicas e invasivas, porém não há evidências suficientes para a tomada de decisão clínica. Objetivo: Revisar as evidências publicadas atualmente sobre eficácia e segurança do tratamento farmacológico e/ou cirúrgico para tratar tremor distônico em qualquer grau de gravidade. Metodologia: Foi uma revisão sistemática conduzida nas bases de dados eletrônicas Medline (via PubMed), Embase, Cochrane Library, Web of Science e Scopus (desde o início até 30 de janeiro de 2024). Dois revisores independentes realizaram a seleção, a extração de dados e a avaliação do risco de viés. A avaliação do risco de viés foi realizada utilizando as ferramentas “Risk-of-bias tool for randomized trials”, “Risk Of Bias In Non-randomized Studies-of Interventions” e a Escala de Newcastle Ottawa Modificada para estudos observacionais. Além disso, a qualidade da certeza de evidências foi avaliada por meio da “Grading os Recommendations Assessment, Development and Evaluation”. Resultados: Foram incluídos 36 estudos, sendo 11 relatos de caso e estudos de coorte cada, nove séries de casos e cinco ensaios clínicos, totalizando 512 participantes. Entre as intervenções descritas estavam tratamentos farmacológicos, estimulação transcraniana e procedimentos invasivos. Conclusão: Entre as intervenções identificadas, observou-se que 63,8% apresentaram relato de Estimulação Cerebral Profunda no qual foi observado provável benefício terapêutico na redução da gravidade do tremor. Os principais efeitos adversos com a realização da Estimulação Cerebral Profunda são disartria, instabilidade da marcha ou ataxia e parestesia.
- Open Access
- 17 February 2026
- Published by Elsevier in NeuroToxicology
- Vol. 113, 103411
Synthetic cannabidiol analogues exhibit lower toxicity than cannabidiol and protect against ethanol-induced apoptosis in SH-SY5Y cells
- 17 February 2026
- Published by Elsevier in NeuroToxicology
- Vol. 113, 103411
Open AccessSynthetic cannabidiol analogues exhibit lower toxicity than cannabidiol and protect against ethanol-induced apoptosis in SH-SY5Y cells
- Open Access
- 3 February 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (7) , 9471-9479
Cannabidiol as a treatment for cocaine use disorder: a scoping review
Cocaine use disorder (CUD) remains a major public health challenge with limited effective therapeutic options. Cannabidiol (CBD) has been proposed as a potential treatment due to its neuroprotective and anti-craving properties. This scoping review aims to synthesize and map the existing evidence from clinical trials evaluating CBD’s effects on craving reduction, relapse prevention, cognitive function, and emotional regulation in individuals with CUD. Although CBD was well tolerated and associated with fewer adverse events than conventional pharmacological treatments, clinical studies included in this review did not demonstrate significant efficacy over placebo in reducing cocaine craving, preventing relapse, or improving cognitive performance, despite promising preclinical outcomes. The review also highlights methodological limitations across studies, including variability in dosage, treatment duration, and study design. Although current evidence does not support CBD as a standalone treatment for CUD, its favorable safety profile suggests potential utility within a broader, multimodal therapeutic framework. Future research should prioritize standardized protocols and explore synergistic combinations with behavioral or pharmacological interventions to enhance treatment efficacy.
- 3 February 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (7) , 9471-9479
Open AccessCannabidiol as a treatment for cocaine use disorder: a scoping review
Cocaine use disorder (CUD) remains a major public health challenge with limited effective therapeutic options. Cannabidiol (CBD) has been proposed as a potential treatment due to its neuroprotective and anti-craving properties. This scoping review aims to synthesize and map the existing evidence from clinical trials evaluating CBD’s effects on craving reduction, relapse prevention, cognitive function, and emotional regulation in individuals with CUD. Although CBD was well tolerated and associated with fewer adverse events than conventional pharmacological treatments, clinical studies included in this review did not demonstrate significant efficacy over placebo in reducing cocaine craving, preventing relapse, or improving cognitive performance, despite promising preclinical outcomes. The review also highlights methodological limitations across studies, including variability in dosage, treatment duration, and study design. Although current evidence does not support CBD as a standalone treatment for CUD, its favorable safety profile suggests potential utility within a broader, multimodal therapeutic framework. Future research should prioritize standardized protocols and explore synergistic combinations with behavioral or pharmacological interventions to enhance treatment efficacy.
- 7 June 2025
- Published by Springer Nature in Neurotoxicity Research
- Vol. 43 (3) , 1-19
Ketamine-Ethanol Combination Decreases Reduced Glutathione Levels and Activates both Intrinsic and Extrinsic Apoptotic Pathways Prior to Neuronal Death in SH-SY5Y Cells
Ketamine is an anesthetic drug that has been illegally used due to its hallucinogenic effects. Its use is often concomitant with drugs such as ethanol, which can cause irreversible damage to the central nervous system. This study investigates the neurotoxicity of ketamine-ethanol combination in human neuroblastoma SH-SY5Y cell line, exploring the mechanisms preceding cell death. Cell viability, oxidative stress parameters, and apoptosis pathways were assessed after 3 and 6 h of drug exposure. A concentration-response curve using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay determined the lowest observed adverse effect levels for ketamine (1 mM; K1) and ethanol (100 mM; E100). After 12, 24 and 48 h, MTT assay revealed a decrease in cell viability, with a possible synergistic effect in K1E100 at 48 h, confirmed by annexin-V/7-aminoactinomycin D flow cytometry analysis, which showed a higher proportion of late apoptotic cells. Mechanisms preceding cell death were assessed by measuring reduced glutathione (GSH) levels, glutathione-related enzymes activities, and apoptosis markers (caspase-8, Bax, Bcl-2, and caspase-3). GSH levels decreased after 6 h in E100 and K1E100. Glutathione peroxidase activity increased for all groups after 3 h and in K1 and K1E100 after 6 h. Glutathione reductase and glutathione S-transferase activities increased only for K1E100 after 3 h. K1E100 also showed increased caspase-8 and Bax expression after 3 and 6 h, respectively, indicating activation of both extrinsic and intrinsic apoptotic pathways. These results suggest that ketamine-ethanol combination induces neurotoxicity by triggering oxidative stress and apoptosis in a time-dependent manner prior to cell death, increasing the risk for neuronal damage compared to individual drug exposure. While these findings are promising, they should be interpreted with caution due to certain limitations, such as variability in enzyme activity measurements, reduced sample size for some markers, and the use of an immortalized, proliferative cell line. Further studies using differentiated neuronal cells are needed to validate and expand these observations.
- 7 June 2025
- Published by Springer Nature in Neurotoxicity Research
- Vol. 43 (3) , 1-19
Ketamine-Ethanol Combination Decreases Reduced Glutathione Levels and Activates both Intrinsic and Extrinsic Apoptotic Pathways Prior to Neuronal Death in SH-SY5Y Cells
Ketamine is an anesthetic drug that has been illegally used due to its hallucinogenic effects. Its use is often concomitant with drugs such as ethanol, which can cause irreversible damage to the central nervous system. This study investigates the neurotoxicity of ketamine-ethanol combination in human neuroblastoma SH-SY5Y cell line, exploring the mechanisms preceding cell death. Cell viability, oxidative stress parameters, and apoptosis pathways were assessed after 3 and 6 h of drug exposure. A concentration-response curve using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay determined the lowest observed adverse effect levels for ketamine (1 mM; K1) and ethanol (100 mM; E100). After 12, 24 and 48 h, MTT assay revealed a decrease in cell viability, with a possible synergistic effect in K1E100 at 48 h, confirmed by annexin-V/7-aminoactinomycin D flow cytometry analysis, which showed a higher proportion of late apoptotic cells. Mechanisms preceding cell death were assessed by measuring reduced glutathione (GSH) levels, glutathione-related enzymes activities, and apoptosis markers (caspase-8, Bax, Bcl-2, and caspase-3). GSH levels decreased after 6 h in E100 and K1E100. Glutathione peroxidase activity increased for all groups after 3 h and in K1 and K1E100 after 6 h. Glutathione reductase and glutathione S-transferase activities increased only for K1E100 after 3 h. K1E100 also showed increased caspase-8 and Bax expression after 3 and 6 h, respectively, indicating activation of both extrinsic and intrinsic apoptotic pathways. These results suggest that ketamine-ethanol combination induces neurotoxicity by triggering oxidative stress and apoptosis in a time-dependent manner prior to cell death, increasing the risk for neuronal damage compared to individual drug exposure. While these findings are promising, they should be interpreted with caution due to certain limitations, such as variability in enzyme activity measurements, reduced sample size for some markers, and the use of an immortalized, proliferative cell line. Further studies using differentiated neuronal cells are needed to validate and expand these observations.
- Open Access
- 1 April 2025
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 4 (4) , 1-12
Prevalence of anxiety, depression, and psychoactive substances use among pharmacy students in Minas Gerais: Impacts of the pandemic and the university environment
Mental disorders affect the population widely, and university students are considered a risk group due to the challenges of academic life. Furthermore, the COVID-19 pandemic has had a major impact on this population, intensifying symptoms of anxiety and depression. On the other hand, there is a high consumption of psychoactive substances among academics, which initially aim to minimize internal tensions, but can, in a chronic manner, harm health. Given this, a quantitative, descriptive, and cross-sectional study was carried out on the presence of anxiety and depression, as well as the use of psychoactive substances among pharmacy students at a public university in the interior of Minas Gerais. Two questionnaires were used for data collection, one for demographic and psycho-emotional assessment and another specific for anxiety and depression, known as the Hospital Anxiety and Depression Scale (HADS). The study population consisted of 350 academics. Of these, 69.43% were female, with an average age of 21.72 years. The data indicate that 39.14% of the interviewees had “probable” anxiety and 25.14% “probable” depression, affecting first-year and last-year students more prominently. In addition, there was a higher prevalence of anxiety in males. Depression, on the other hand, affected women more. Regarding the social context, it is observed that both the university and the COVID-19 pandemic increased the prevalence of anxiety and depression. Furthermore, 64.86% of the participants used psychoactive substances, with alcohol and anxiolytics and/or antidepressants being the most used. Thus, the impact of the university and the pandemic on mental illnesses is clear. Furthermore, the high use of psychoactive substances is worrying, as it can generate secondary damage. Therefore, it is suggested that educational measures for preventing psychoactive substance use, as well as improvements in programs related to mental health.
- 1 April 2025
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 4 (4) , 1-12
Open AccessPrevalence of anxiety, depression, and psychoactive substances use among pharmacy students in Minas Gerais: Impacts of the pandemic and the university environment
Mental disorders affect the population widely, and university students are considered a risk group due to the challenges of academic life. Furthermore, the COVID-19 pandemic has had a major impact on this population, intensifying symptoms of anxiety and depression. On the other hand, there is a high consumption of psychoactive substances among academics, which initially aim to minimize internal tensions, but can, in a chronic manner, harm health. Given this, a quantitative, descriptive, and cross-sectional study was carried out on the presence of anxiety and depression, as well as the use of psychoactive substances among pharmacy students at a public university in the interior of Minas Gerais. Two questionnaires were used for data collection, one for demographic and psycho-emotional assessment and another specific for anxiety and depression, known as the Hospital Anxiety and Depression Scale (HADS). The study population consisted of 350 academics. Of these, 69.43% were female, with an average age of 21.72 years. The data indicate that 39.14% of the interviewees had “probable” anxiety and 25.14% “probable” depression, affecting first-year and last-year students more prominently. In addition, there was a higher prevalence of anxiety in males. Depression, on the other hand, affected women more. Regarding the social context, it is observed that both the university and the COVID-19 pandemic increased the prevalence of anxiety and depression. Furthermore, 64.86% of the participants used psychoactive substances, with alcohol and anxiolytics and/or antidepressants being the most used. Thus, the impact of the university and the pandemic on mental illnesses is clear. Furthermore, the high use of psychoactive substances is worrying, as it can generate secondary damage. Therefore, it is suggested that educational measures for preventing psychoactive substance use, as well as improvements in programs related to mental health.
- 27 March 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 996, 177552
Minocycline treatment attenuates high-refined carbohydrate diet-induced gut bacterial dysbiosis, anxiety-like behaviour, and cardiac damage in mice
- 27 March 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 996, 177552
Minocycline treatment attenuates high-refined carbohydrate diet-induced gut bacterial dysbiosis, anxiety-like behaviour, and cardiac damage in mice
- 30 January 2025
- Published by Elsevier in Reproductive Toxicology
- Vol. 132, 108849
Gestational triclosan exposure and its effects on childneurodevelopment – A systematic review
- 30 January 2025
- Published by Elsevier in Reproductive Toxicology
- Vol. 132, 108849
Gestational triclosan exposure and its effects on childneurodevelopment – A systematic review
- 28 January 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (6) , 6561-6577
Effectiveness and safety of the use of sodium nitrite in patients with hypertension and pulmonary hypertension: a scoping review
Evidence suggests that sodium nitrite may be effective in the treatment of hypertension and pulmonary hypertension. However, its use remains debated due to safety concerns. In response, a scoping review was conducted to map current knowledge on the efficacy and safety of sodium nitrite in patients with hypertension or pulmonary hypertension, addressing the question: What evidence supports the effectiveness and safety of using sodium nitrite in these patients? The databases MEDLINE (PubMed), EMBASE, Scopus, Web of Science, and LILACS were searched for clinical studies on hypertensive patients at any disease stage without restrictions on age, sex, ethnicity, publication date, or status. The primary outcomes analyzed were the efficacy and safety of sodium nitrite. A total of nine articles were included, eight from databases and one from gray literature. Sample sizes ranged from 5 to 36 patients, with sodium nitrite doses between 240 µg/kg/h and 325 mg. Five studies showed positive results for treating essential hypertension. Regarding safety, only one study raised concerns about adverse effects, probably due to the high dose that was used. In pulmonary hypertension patients classified as groups 2, 3, and 5, four studies suggested sodium nitrite was effective and safe, but it was ineffective in group 1. The studies included several significant limitations that should be considered. As such, the current evidence is insufficient to definitively confirm the efficacy and safety of sodium nitrite in hypertensive patients. Further research with larger sample sizes is necessary to obtain more conclusive results.
- 28 January 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (6) , 6561-6577
Effectiveness and safety of the use of sodium nitrite in patients with hypertension and pulmonary hypertension: a scoping review
Evidence suggests that sodium nitrite may be effective in the treatment of hypertension and pulmonary hypertension. However, its use remains debated due to safety concerns. In response, a scoping review was conducted to map current knowledge on the efficacy and safety of sodium nitrite in patients with hypertension or pulmonary hypertension, addressing the question: What evidence supports the effectiveness and safety of using sodium nitrite in these patients? The databases MEDLINE (PubMed), EMBASE, Scopus, Web of Science, and LILACS were searched for clinical studies on hypertensive patients at any disease stage without restrictions on age, sex, ethnicity, publication date, or status. The primary outcomes analyzed were the efficacy and safety of sodium nitrite. A total of nine articles were included, eight from databases and one from gray literature. Sample sizes ranged from 5 to 36 patients, with sodium nitrite doses between 240 µg/kg/h and 325 mg. Five studies showed positive results for treating essential hypertension. Regarding safety, only one study raised concerns about adverse effects, probably due to the high dose that was used. In pulmonary hypertension patients classified as groups 2, 3, and 5, four studies suggested sodium nitrite was effective and safe, but it was ineffective in group 1. The studies included several significant limitations that should be considered. As such, the current evidence is insufficient to definitively confirm the efficacy and safety of sodium nitrite in hypertensive patients. Further research with larger sample sizes is necessary to obtain more conclusive results.
- 24 October 2024
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 55 (4) , 3899-3908
Evaluation of the perspective of pharmacists on antimicrobial stewardship and the barriers to its consolidation in hospitals: a cross-sectional study
Antimicrobial Stewardship Programs (ASPs) are associated with positive outcomes, but seem to be consolidated in few hospitals. This study aimed to evaluate ASPs in Brazilian hospitals and the barriers to their consolidation from the pharmacists’ perspective. This is a cross-sectional study. Data were collected through an online questionnaire applied to hospital pharmacists. Data analysis was performed by descriptive statistics and Spearman's ordinal correlation test. A total of 83 pharmacists participated in the study and 45.8% stated that the hospital in which they worked had an ASP. The ASPs were predominantly implemented in public hospitals, with a greater number of beds in the intensive care unit and beds in general. The main barriers to the consolidation of ASPs were: reduced number of pharmacists, time allocated to other demands of the pharmacy, the ineffectiveness of the communication process with doctors, and lack of access to reliable information about antimicrobials in the hospital. Pharmacists that work in hospitals where ASPs were implemented were more confident (p = 0.000) and with a better perception of the barriers that prevent their consolidation (p = 0.003. The ASP was commonly adopted in public hospitals with a greater number of beds. The main obstacles to consolidation were infrastructure, economic, and educational resources.
- 24 October 2024
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 55 (4) , 3899-3908
Evaluation of the perspective of pharmacists on antimicrobial stewardship and the barriers to its consolidation in hospitals: a cross-sectional study
Antimicrobial Stewardship Programs (ASPs) are associated with positive outcomes, but seem to be consolidated in few hospitals. This study aimed to evaluate ASPs in Brazilian hospitals and the barriers to their consolidation from the pharmacists’ perspective. This is a cross-sectional study. Data were collected through an online questionnaire applied to hospital pharmacists. Data analysis was performed by descriptive statistics and Spearman's ordinal correlation test. A total of 83 pharmacists participated in the study and 45.8% stated that the hospital in which they worked had an ASP. The ASPs were predominantly implemented in public hospitals, with a greater number of beds in the intensive care unit and beds in general. The main barriers to the consolidation of ASPs were: reduced number of pharmacists, time allocated to other demands of the pharmacy, the ineffectiveness of the communication process with doctors, and lack of access to reliable information about antimicrobials in the hospital. Pharmacists that work in hospitals where ASPs were implemented were more confident (p = 0.000) and with a better perception of the barriers that prevent their consolidation (p = 0.003. The ASP was commonly adopted in public hospitals with a greater number of beds. The main obstacles to consolidation were infrastructure, economic, and educational resources.
- 8 September 2024
- Published by Wiley in Cell Biochemistry and Function
- Vol. 42 (7) , e4119
Curcumin Prevents Renal Damage of l‐NAME Induced Hypertension in by Reducing MMP‐2 and MMP‐9
In the present study, we investigated whether curcumin administration would interfere with the main renal features of l‐NAME‐induced hypertension model. For this purpose, we conducted both in vitro and in vivo experiments to evaluate renal indicators of inflammation, oxidative stress, and metalloproteinases (MMPs) expression/activity. Hypertension was induced by l‐NAME (70 mg/kg/day), and Wistar rats from both control and hypertensive groups were treated with curcumin (50 or 100 mg/kg/day; gavage) or vehicle for 14 days. Blood and kidneys were collected to determine serum creatinine levels, histological alterations, oxidative stress, MMPs expression and activity, and ED1 expression. l‐NAME increased blood pressure, but both doses of curcumin treatment reduced these values. l‐NAME treatment increased creatinine levels, glomeruli area, Bowman's space, kidney MMP‐2 activity, as well as MMP‐9 and ED1 expression, and reduced the number of glomeruli. Curcumin treatment prevented the increase in creatinine levels, MMP‐2 activity, and reduced MMP‐2, MMP‐9, ED1, and superoxide levels, as well as increased superoxide dismutase activity and partially prevented glomeruli alterations. Moreover, curcumin directly inhibited MMP‐2 activity in vitro. Thus, our main findings demonstrate that curcumin reduced l‐NAME‐induced hypertension and renal glomerular alterations, inhibited MMP‐2 and MMP‐9 expression/activity, and reduced oxidative stress and inflammatory processes, which may indirectly impact hypertension‐induced renal outcomes.
- 8 September 2024
- Published by Wiley in Cell Biochemistry and Function
- Vol. 42 (7) , e4119
Curcumin Prevents Renal Damage of l‐NAME Induced Hypertension in by Reducing MMP‐2 and MMP‐9
In the present study, we investigated whether curcumin administration would interfere with the main renal features of l‐NAME‐induced hypertension model. For this purpose, we conducted both in vitro and in vivo experiments to evaluate renal indicators of inflammation, oxidative stress, and metalloproteinases (MMPs) expression/activity. Hypertension was induced by l‐NAME (70 mg/kg/day), and Wistar rats from both control and hypertensive groups were treated with curcumin (50 or 100 mg/kg/day; gavage) or vehicle for 14 days. Blood and kidneys were collected to determine serum creatinine levels, histological alterations, oxidative stress, MMPs expression and activity, and ED1 expression. l‐NAME increased blood pressure, but both doses of curcumin treatment reduced these values. l‐NAME treatment increased creatinine levels, glomeruli area, Bowman's space, kidney MMP‐2 activity, as well as MMP‐9 and ED1 expression, and reduced the number of glomeruli. Curcumin treatment prevented the increase in creatinine levels, MMP‐2 activity, and reduced MMP‐2, MMP‐9, ED1, and superoxide levels, as well as increased superoxide dismutase activity and partially prevented glomeruli alterations. Moreover, curcumin directly inhibited MMP‐2 activity in vitro. Thus, our main findings demonstrate that curcumin reduced l‐NAME‐induced hypertension and renal glomerular alterations, inhibited MMP‐2 and MMP‐9 expression/activity, and reduced oxidative stress and inflammatory processes, which may indirectly impact hypertension‐induced renal outcomes.